• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Duke Street backs Air Products homecare carve-out

  • Alice Murray
  • Alice Murray
  • 04 December 2013
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Duke Street has backed the management buyout of NYSE-listed Air Products & Chemicals' UK homecare business.

According to Duke Street partner Charlie Troup, who led the deal, Air Products was looking to divest its home oxygen services-focused business around the world, and the private equity house was keen to pick up the UK and Ireland division.

The carve-out took around 18 months to complete because of legal and structural complexities. Duke Street gained exclusivity on the deal at an early stage.

Baywater Healthcare

  • DEAL:

    MBO

  • LOCATION:

    Crewe

  • SECTOR:

    Medical equipment

  • VENDOR:

    Air Products & Chemicals

The investment was structured as a classic deal-by-deal, with equity coming from the GP and a co-investor. The financial structure of the deal was arranged prior to Duke Street's tie-up with Tikehau, so did not use cash from its recently developed fund that will enable the investor to act mroe swiftly on new deals.

According to Troup, Duke Street will support the new company's growth by building on its domiciliary care activities. The buyout house believes that as domiciliary care is increasingly favoured by the government as a better and more cost effective way of patient care, Air Product's homecare business is well-placed to take advantage of increased demand in this sector. Duke Street plans to add more services onto the existing business, and will also look to develop its telehealth offering. 

Company
Following the deal, Air Products' homecare business has changed its name to Baywater Healthcare.

The company supplies home oxygen, sleep apnoeatherapy, ventilation and tele-health services to patients at home. The business serves more than 25,000 patients and holds a number of public healthcare contracts with the NHS in the UK and the HSE in Ireland.

Home Oxygen Services delivers oxygen to patients at home through a cylinder or a concentrator. The company receives orders from patients and clinicians through its call centre. Patients served typically suffer from chronic obstructive pulmonary disease or congestive heart failure.

People
Adam Sullivan is CEO of the newco. Charlie Troup, partner at Duke Street, led the deal alongside investment director Ben Long.

Duke Street has installed Douglas Quinn as the company's new chairman and Howard Jones as finance director.

Advisers
Management – Altium, Simon Lord, Chris Hopwood (Corporate finance); Turner Parkinson, James Sheridan, David Hayes (Legal); Grant Thornton, John Loebl (Tax).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • UK / Ireland
  • Healthcare
  • Duke Street
  • United Kingdom

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013